Back to search
FDAFDA · Food and drugs·Recall number D-0177-2016

PGE 30mcg/ml Injection, 10 mL vials, Rx, B & B Health Mart Pharmacy, Bellflower, CA

Published November 18, 2015 · Recall initiated: October 7, 2015

Summary

FDA records drug Class II recall D-0177-2016, published November 18, 2015 and initiated October 7, 2015. Recalling firm: Pacific Healthcare, Inc dba B&B Pharmacy; Status: Terminated; Reported quantity: 4 vials; Lot: 07062015@8, exp 1/2/2016; 07162015@7, exp 1/12/2016; 07272015@5, exp 1/23/2016; 08142015@9, exp 2/10/2016. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Pacific Healthcare, Inc dba B&B Pharmacy
Distributor
CA and NJ
Lot
07062015@8, exp 1/2/2016; 07162015@7, exp 1/12/2016; 07272015@5, exp 1/23/2016; 08142015@9, exp 2/10/2016
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was PGE 30mcg/ml Injection, 10 mL vials, Rx, B & B Health Mart Pharmacy, Bellflower, CA recalled?

Yes. FDA published recall D-0177-2016 on November 18, 2015. Reported hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

What should I do if I have this product?

Voluntary: Firm initiated · Letter